Cargando…
Clinical utility of early use of tolvaptan in very elderly patients with acute decompensated heart failure
OBJECTIVE: The establishment of an optimal strategy for elderly patients with acute decompensated heart failure (ADHF) is currently an important issue. Particularly in very elderly (VE) patients, ADHF is associated with a poor prognosis. We therefore aimed to evaluate the efficacy and safety of the...
Autores principales: | Niikura, Hiroki, Iijima, Raisuke, Anzai, Hitoshi, Kogame, Norihiro, Fukui, Ryo, Takenaka, Hiroki, Kobayashi, Nobuyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kare Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689052/ https://www.ncbi.nlm.nih.gov/pubmed/28777097 http://dx.doi.org/10.14744/AnatolJCardiol.2017.7628 |
Ejemplares similares
-
Tolvaptan in the very elderly with acute decompensated heart failure-a therapeutic option worth of consideration
por: Ndrepepa, Gjin
Publicado: (2017) -
Author's Reply
por: Niikura, Hiroki, et al.
Publicado: (2018) -
Long-term administration of Tolvaptan to patients with decompensated cirrhosis
por: Kanayama, Kengo, et al.
Publicado: (2020) -
The Successful Removal of Two Retrievable Inferior Vena Cava (IVC) Filters after 67 Days in a Patient with a Double IVC
por: Niikura, Hiroki, et al.
Publicado: (2017) -
Prognostic Impact of the Early Use of Tolvaptan in Elderly Patients with Acute Decompensated Heart Failure
por: Okada, Tomoaki, et al.
Publicado: (2023)